How glycomics can be used to measure Chronic inflammation? Chronic inflammation is a major health concern worldwide, associated with numerous diseases, including cancer, cardiovascular disease, and diabetes. While inflammation is a natural response to injury or infection, persistent or chronic inflammation can lead to tissue damage and contribute to the development of various diseases. Recent …
Introduction to Avenna In this video, we explain how our in-vitro diagnostic platform technology- GlyHealth can enhance healthcare for chronic inflammatory diseases. We explain the benefits of our biomarkers for different members of healthcare ecosystem, including clinicians and drug development companies. BACK TO MEDIA GALLERY
Immunofraility Test. Instruction video In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.